Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lauria, Giuseppe
NCT05508074 / 2021-003875-32: Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol)	Completed	2	51	Europe	IFB-088 50mg/day, IFB-088, Icerguastat, Placebo, Riluzole 100mg/day, Riluzole	InFlectis BioScience, InFlectis BioScience,	Amyotrophic Lateral Sclerosis, ALS	11/24	01/25
PROFUNDUS, NCT04430400: Integrated Diagnostic Algorithm for Acute Aortic Syndromes	Completed	N/A	3023	Europe, RoW	integrated diagnostic algorithm	Azienda Ospedaliero-Universitaria Careggi	Acute Aortic Syndrome	01/23	01/23

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lauria, Giuseppe
NCT05508074 / 2021-003875-32: Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol)	Completed	2	51	Europe	IFB-088 50mg/day, IFB-088, Icerguastat, Placebo, Riluzole 100mg/day, Riluzole	InFlectis BioScience, InFlectis BioScience,	Amyotrophic Lateral Sclerosis, ALS	11/24	01/25
PROFUNDUS, NCT04430400: Integrated Diagnostic Algorithm for Acute Aortic Syndromes	Completed	N/A	3023	Europe, RoW	integrated diagnostic algorithm	Azienda Ospedaliero-Universitaria Careggi	Acute Aortic Syndrome	01/23	01/23